August 2026 in “Pakistan Journal of Pharmaceutical Sciences” In rats with cyclophosphamide-induced hair loss, this study found that applying cetirizine HCl-loaded emulgel with microneedling stimulated hair growth, suggesting a potentially safer alternative to minoxidil for treating chemotherapy-induced alopecia.
August 2026 in “Clinical and Translational Science” This study evaluated two bimatoprost 1% formulations for androgenetic alopecia in men, finding both formulations achieved effective drug concentrations in the scalp with no significant differences between them, and were well tolerated over the 14-day application period.
July 2026 in “Journal of the American Academy of Dermatology” Hispanic/Latinx people are underrepresented in alopecia clinical trials, and more inclusive research is needed.
May 2026 in “International Journal of Dermatology” IL-17 and IL-23 inhibitors may cause hair loss.
April 2026 in “Clinical Case Reports” This case study suggests that "celiac hepatitis" should be considered in patients with unexplained liver dysfunction, highlighting the importance of recognizing celiac disease to avoid misdiagnosis and allow reversal of liver abnormalities with proper treatment.
March 2026 in “European journal of ecology, biology and agriculture.” This study found significantly higher levels of Toll-Like Receptor 4, interferon gamma, and interleukin-17 in Iraqi patients with alopecia areata compared to controls, suggesting these immune markers play a crucial role in the disease's development and could be targets for future treatments.
January 2026 in “Mendeley Data” January 2026 in “Mendeley Data” January 2026 in “International Journal of Dermatology” This study analyzed social media posts to assess pet toxicosis from topical minoxidil exposure, finding that many pet owners were unaware of its toxicity risks, particularly for cats, and highlighted a significant need for increased educational efforts to prevent such incidents.
December 2025 in “International Journal of Dermatology” This systematic review reported that while combining low-dose oral minoxidil with Janus kinase inhibitors may enhance treatment outcomes in alopecia areata, the evidence remains weak due to limited sample sizes and potential publication bias, and more rigorous trials are necessary to assess efficacy and safety.
November 2025 in “Basic and Clinical Andrology” This systematic review and meta-analysis found that male first-degree relatives of women with PCOS have increased rates of metabolic issues, hormonal imbalances, and androgenic features compared to controls, suggesting a male equivalent of PCOS.
October 2025 in “Journal of Bahria University Medical and Dental College” In this study, among women with polycystic ovary syndrome, free testosterone was most frequently elevated, highlighting its importance in biochemical assessment and suggesting the need for age-related interpretation of DHEAS levels.
July 2025 in “Future Journal of Pharmaceuticals and Health Sciences” This study developed a polyherbal chocolate formulation aimed at managing PCOS and hormonal balance, finding that formulation F2 showed excellent organoleptic properties and stability, with future in vivo studies being suggested.
May 2025 in “Journal of Cutaneous Medicine and Surgery” Online resources for hair loss need better quality and readability.
April 2025 in “Pharmaceuticals” This study found that novel thiol-reactive cross-linking agents, particularly APA, significantly improved the tensile strength and elasticity of human hair fibers by effectively regenerating disulfide bridges, with potential applications for advanced hair repair treatments in the cosmetic industry.
April 2025 in “Otorhinolaryngology Clinics - An International Journal” This case report highlights the critical role of preoperative histopathology in accurately diagnosing and treating ambiguous cutaneous lesions in the ear, nose, and throat area, emphasizing that reliance solely on clinical features can lead to misdiagnosis.
January 2025 in “International Journal of Pharmaceutical Research and Applications” This study examines the formulation and effectiveness of a natural hair gel made with Mussaenda frondosa leaf extract for its potential anti-dandruff benefits, highlighting its safety and additional advantages for promoting hair and scalp health.
October 2024 in “Archives of Dermatological Research”
September 2024 in “Journal of Health and Rehabilitation Research” This study found that telogen effluvium, a temporary hair loss condition, is significantly associated with COVID-19 recovery, particularly affecting females.
March 2024 in “Journal of Animal Reproduciton and Biotechnology” In this case report, researchers document a rare instance of dystocia in a beetal breed goat from Pakistan caused by a fetal monster known as Perosomus Elumbis, highlighting the need for understanding and managing such conditions to ensure successful delivery outcomes.
In this nonrandomized controlled study, topical betamethasone dipropionate lotion was found to be significantly more effective for hair regrowth in patients with alopecia areata compared to topical minoxidil solution, with 74% showing efficacy versus 42%, respectively.
February 2024 in “Practical Diabetes” This study showed that spironolactone effectively reduces morbidity and mortality in moderate to severe heart failure with reduced ejection fraction, but its benefits in heart failure with preserved ejection fraction are less clear.
December 2023 in “International Journal of Health and Pharmaceutical” This study found that a mixture of 80% coconut oil and 20% candlenut oil effectively stimulated hair development in Wistar rats, which may be attributed to the high lauric acid content in coconut oil.
November 2023 in “Scholars journal of applied medical sciences” This study conducted in Rabat surveyed 100 individuals with afro-textured hair to identify plant-based treatments, finding twelve plant species purportedly effective in managing hair issues, with Ricinus communis, Cocos nucifera, and Aloe barbadensis being the most frequently cited.
November 2023 in “Pakistan Journal of Health Sciences” This study found that clobetasol propionate 0.05% was significantly more effective in stimulating hair re-growth in alopecia areata patients compared to topical tacrolimus 0.1%, with an excellent response observed in 74.3% of the clobetasol group versus 40% in the tacrolimus group.
October 2023 in “Journal of Pakistan Association of Dermatologists” In this case report, a 33-year-old woman with severe post-COVID alopecia areata experienced hair regrowth after two months of treatment with topical minoxidil, tacrolimus, and scalp PRP with micro-needling, though some bald patches reoccurred.
September 2023 in “Research Square (Research Square)” In this study, overweight women with polycystic ovarian syndrome who took evening primrose oil for 10 weeks experienced significant reductions in BMI, LDL, and total cholesterol levels, alongside hormonal changes such as decreased LH, FSH, and testosterone levels, and increased estrogen.
This study found that most participants had limited awareness of PCOS and its major risk factors, underscoring a need for increased education on the condition.
March 2022 in “Research Square (Research Square)” This study found that replacing components with artificial sebum in the modified Leeming and Notman agar medium significantly increased the growth yield of Malassezia restricta.
January 2022 in “European journal of anatomy” This study reports a rare case of polyorchidism in a 96-year-old male cadaver, suggesting a new classification based on anatomical and histological findings to aid in accurate diagnosis.